We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+11.74%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$71.5B
AUM Growth
+$3.66B
(+5.4%)
Cap. Flow
-$2.85B
Cap. Flow
% of AUM
-3.99%
Top 10 Holdings %
Top 10 Hldgs %
18.22%
Holding
1,538
New
294
Increased
526
Reduced
448
Closed
234
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$268M |
| 2 |
General Motors
GM
|
+$263M |
| 3 |
AstraZeneca
AZN
|
+$235M |
| 4 |
Vale
VALE
|
+$226M |
| 5 |
Oracle
ORCL
|
+$225M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$945M |
| 2 |
Microsoft
MSFT
|
+$606M |
| 3 |
Canadian Natural Resources
CNQ
|
+$552M |
| 4 |
Bank of America
BAC
|
+$490M |
| 5 |
AbbVie
ABBV
|
+$432M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.7% |
| 2 | Healthcare | 20.13% |
| 3 | Consumer Discretionary | 15.62% |
| 4 | Financials | 9.5% |
| 5 | Energy | 7.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Jazz Pharmaceuticals
JAZZ
$16.9B
| $109M | 0.15% |
684,517
+182,721
| +36% | +$26.8M |
|
152
PVH
PVH
$3.97B
| $107M | 0.15% |
1,513,465
+15,457
| +1% | +$921K |
|
153
Gerdau
GGB
$9.8B
| $105M | 0.15% |
+23,855,591
| New | +$103M |
|
154
Zoetis
ZTS
$29.6B
| $104M | 0.14% |
706,469
-305,345
| -30% | -$45.2M |
|
|
CNH
155
CNH Industrial
CNH
$17.2B
| $103M | 0.14% |
6,412,063
+2,289,502
| +56% | +$33M |
|
156
Paychex
PAYX
$42.6B
| $101M | 0.14% |
873,247
-228,864
| -21% | -$26.8M |
|
157
Molina Healthcare
MOH
$10.4B
| $101M | 0.14% |
305,586
-27,078
| -8% | -$9.2M |
|
158
lululemon athletica
LULU
$14.2B
| $101M | 0.14% |
314,702
+173,980
| +124% | +$57.2M |
|
159
Vipshop
VIPS
$7.42B
| $99.7M | 0.14% |
7,305,777
+811,015
| +12% | +$8.05M |
|
160
Mondelez International
MDLZ
$78.6B
| $98.8M | 0.14% |
1,483,037
+43,490
| +3% | +$2.75M |
|
161
Royalty Pharma
RPRX
$25.6B
| $98.8M | 0.14% |
2,498,870
+577,444
| +30% | +$24.1M |
|
162
DexCom
DXCM
$32.7B
| $98.5M | 0.14% |
870,247
+776,111
| +824% | +$85.2M |
|
163
Salesforce
CRM
$159B
| $98.1M | 0.14% |
740,148
+14,862
| +2% | +$2.17M |
|
164
Alcon
ALC
$35.1B
| $97.4M | 0.14% |
1,423,390
+466,456
| +49% | +$29.8M |
|
165
Paycom
PAYC
$9.5B
| $97.2M | 0.14% |
313,265
+39,475
| +14% | +$12.7M |
|
166
LyondellBasell Industries
LYB
$19.7B
| $96.7M | 0.14% |
1,164,652
-241,688
| -17% | -$19.8M |
|
167
VF Corp
VFC
$5.81B
| $96.7M | 0.14% |
3,502,156
+1,128,539
| +48% | +$33.2M |
|
168
Ralph Lauren
RL
$23.7B
| $96.2M | 0.13% |
910,583
+109,235
| +14% | +$10.9M |
|
169
Kohl's
KSS
$2.16B
| $94.8M | 0.13% |
3,753,370
+166,199
| +5% | +$4.71M |
|
|
EA
170
DELISTED
Electronic Arts
EA
| $94M | 0.13% |
769,004
+104,196
| +16% | +$13.1M |
|
171
Boyd Gaming
BYD
$5.95B
| $93.6M | 0.13% |
1,716,764
+81,217
| +5% | +$4.57M |
|
172
Wyndham Hotels & Resorts
WH
$5.33B
| $93.4M | 0.13% |
1,309,337
-78,035
| -6% | -$5.52M |
|
173
Honda
HMC
$41B
| $92.5M | 0.13% |
4,047,327
-283,544
| -7% | -$6.57M |
|
174
Aramark
ARMK
$14.7B
| $90.8M | 0.13% |
3,041,665
+947,294
| +45% | +$26.1M |
|
175
ASE Group
ASX
$85B
| $90.2M | 0.13% |
14,383,989
+2,075,489
| +17% | +$12.2M |
|
Similar funds
VGA
Arrowstreet Capital's Q4 2022 Portfolio in Review
As of Q4 2022, Arrowstreet Capital held 1,538 positions worth $71.5B, up 5.4% from $67.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital withdrew a net $2.85B in Q4 2022, closing 234 positions and reducing 448 holdings. Its most notable exit was AbbVie, an estimated $432M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Arrowstreet Capital opened a new position in Gerdau worth $105M.
- Arrowstreet Capital's largest Q4 2022 buy was Gerdau: 23,855,591 shares worth $105M.
- Arrowstreet Capital added most to Visa in Q4 2022, an estimated $268M increase.
- Arrowstreet Capital's biggest Q4 2022 reduction was JPMorgan Chase, cutting an estimated $945M.
- Arrowstreet Capital fully exited AbbVie in Q4 2022, selling an estimated $432M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $71.5B portfolio in Q4 2022.
- Arrowstreet Capital opened 294 new positions and closed 234 in Q4 2022.
- Arrowstreet Capital's portfolio value rose 5.4% quarter-over-quarter to $71.5B.
Based on Arrowstreet Capital's 13F filing for Q4 2022, filed 14 Feb 2023.